On December 16, 2009, the Securities and Exchange Commission voted 4-1 to approve amendments to its rules that will require expanded disclosure requirements for U.S. public companies, effective February 28, 2010, including:
- Providing narrative disclosure of the Company’s compensation policies and practices as they may relate to the Company’s risk management;
- Revising reporting requirements for stock and option awards in the summary compensation table;
- Requiring enhanced disclosure of the background and qualifications of directors and nominees, including greater litigation disclosure, and the role of diversity in the nomination process;
- Requiring new disclosure about a Company’s Board leadership structure and the Board’s role in risk oversight;
- Requiring new disclosure regarding a Company’s use of compensation consultants, potential conflicts of interest and the fees paid to such consultants; and
- Reporting of voting results on Form 8-K within four days of the annual meeting, rather than waiting for the next Form 10-Q or 10-K.
For additional information, please contact:
Megan L. Mehalko at (216) 363-4487 or mmehalko@beneschlaw.com
Latest News
Medical First, Recreational Later? DOJ’s Cannabis Order and the Stakes Ahead
DOJ’s April 2026 order immediately moved FDA-approved and state-licensed medical cannabis to Schedule III, removing harsh tax penalties for medical operators, while leaving adult-use cannabis under stricter Schedule I controls pending further administrative review.
New Sentencing Guidelines for Economic Crimes Effective November 1, 2026
In March we reported on the U.S. Sentencing Commission’s proposed amendments to the Federal Sentencing Guidelines (the “Guidelines”). On April 16, 2026, the bipartisan United States Sentencing Commission (the “Commission”) voted unanimously to adopt that package of amendments, without modification.
Judicial Green Light: Court Upholds NLRB’s Cemex Decision
On April 21st, 2026, the U.S. Court of Appeals for the Ninth Circuit upheld the National Labor Relations Board’s (“NLRB”) decision in Cemex Construction Materials Pacific, LLC., reinforcing a significant shift in federal labor law governing union recognition and employer conduct during organizing campaigns.
The LEAD Model—Kidney Care’s Value-Based Care Journey LEADs Here
The new LEAD Model, launching in 2027, is CMS’s next-generation value-based care framework for kidney care, integrating CKD and ESRD patients into standard ACOs with a 10-year benchmark period, new payment options and greater flexibility for nephrology-led organizations.